Table 4.
Micronucleus frequency induced by vildagliptin and sitagliptin in cultured human lymphocytes
| Test substance (µg/ml) | Concentration (µg/ml) | Period | S9 mix | BN cells according to MN number | % MN ± SE | Distribution of cells according to nucleus number | NBI ± SE | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | >3 | 1 | 2 | 3 | 4 | ||||||
| DMSO | 1 | 24 h | – | 7970 | 30 | – | – | – | 0.38 ± 0.08 | 731 | 2916 | 53 | 300 | 1.98 ± 0.07 |
| MMC | 0.16 | 24 h | – | 7779 | 216 | 5 | – | – | 2.76 ± 0.44 | 1917 | 2077 | 1 | 9 | 1.53 ± 0.13 |
| Vildagliptin | 125 | 24 h | – | 7972 | 25 | 3 | – | – | 0.35 ± 0.05 | 781 | 2844 | 60 | 320 | 1.98 ± 0.05 |
| Vildagliptin | 250 | 24 h | – | 7977 | 23 | – | – | – | 0.29 ± 0.06 | 767 | 2918 | 47 | 266 | 1.95 ± 0.07 |
| Vildagliptin | 500 | 24 h | – | 7980 | 19 | 1 | – | – | 0.25 ± 0.07 | 1041 | 2682 | 71 | 236 | 1.89 ± 0.16 |
| DMSO | 1 | 48 h | – | 7965 | 32 | 2 | 1 | – | 0.44 ± 0.13 | 731 | 2916 | 53 | 300 | 1.98 ± 0.03 |
| MMC | 0.16 | 48 h | – | 6755 | 1088 | 143 | – | – | 15.39 ± 3.00 | 1917 | 2077 | 1 | 9 | 1.41 ± 0.06 |
| Vildagliptin | 125 | 48 h | – | 7978 | 22 | – | – | – | 0.28 ± 0.07 | 781 | 2844 | 60 | 320 | 1.91 ± 0.09 |
| Vildagliptin | 250 | 48 h | – | 7968 | 29 | – | – | – | 0.36 ± 0.07 | 767 | 2918 | 47 | 266 | 1.89 ± 0.07 |
| Vildagliptin | 500 | 48 h | – | 7983 | 15 | 2 | – | – | 0.21 ± 0.07 | 1041 | 2682 | 71 | 236 | 1.99 ± 0.05 |
| DMSO | 1 | 3 h | + | 7968 | 29 | 3 | – | – | 0.40 ± 0.11 | 731 | 2916 | 53 | 300 | 1.97 ± 0.09 |
| CP | 45 | 3 h | + | 7831 | 161 | 8 | – | – | 2.11 ± 0.26 | 1968 | 1722 | 135 | 175 | 1.63 ± 0.09 |
| Vildagliptin | 125 | 3 h | + | 7967 | 31 | 2 | – | – | 0.41 ± 0.13 | 781 | 2844 | 60 | 320 | 1.99 ± 0.05 |
| Vildagliptin | 250 | 3 h | + | 7974 | 23 | 3 | – | – | 0.33 ± 0.13 | 767 | 2918 | 47 | 266 | 1.98 ± 0.10 |
| Vildagliptin | 500 | 3 h | + | 7985 | 14 | 1 | – | – | 0.19 ± 0.09 | 1041 | 2682 | 71 | 236 | 1.96 ± 0.05 |
| DMSO | 1 | 24 h | – | 7979 | 20 | 1 | 0 | 0 | 0.26 ± 0.04 | 590 | 3220 | 59 | 228 | 2.03 ± 0.08 |
| MMC | 0.16 | 24 h | – | 7735 | 255 | 8 | 1 | 1 | 3.31 ± 1.06 | 1512 | 2450 | 8 | 10 | 1.62 ± 0.06 |
| Sitagliptin | 250 | 24 h | – | 7964 | 35 | 1 | 0 | 0 | 0.45 ± 0.24 | 579 | 3173 | 48 | 200 | 1.97 ± 0.04 |
| Sitagliptin | 500 | 24 h | – | 7969 | 29 | 2 | 0 | 0 | 0.39 ± 0.19 | 812 | 3035 | 39 | 114 | 1.86 ± 0.08 |
| Sitagliptin | 1000 | 24 h | – | 7976 | 24 | 0 | 0 | 0 | 0.30 ± 0.07 | 1289 | 2664 | 8 | 25 | 1.69 ± 0.08* |
| DMSO | 1 | 48 h | – | 7948 | 48 | 4 | 0 | 0 | 0.65 ± 0.34 | 631 | 3089 | 50 | 230 | 1.97 ± 0.05 |
| MMC | 0.16 | 48 h | – | 6361 | 1448 | 163 | 24 | 4 | 20.49 ± 3.83 | 2130 | 1798 | 57 | 15 | 1.49 ± 0.08 |
| Sitagliptin | 250 | 48 h | – | 7968 | 31 | 1 | 0 | 0 | 0.40 ± 0.15 | 871 | 3062 | 17 | 50 | 1.81 ± 0.06 |
| Sitagliptin | 500 | 48 h | – | 7961 | 36 | 3 | 0 | 0 | 0.49 ± 0.20 | 1536 | 2446 | 6 | 12 | 1.62 ± 0.10 |
| Sitagliptin | 1000 | 48 h | – | 7968 | 32 | 0 | 0 | 0 | 0.40 ± 0.09 | 3259 | 737 | 4 | 0 | 1.19 ± 0.05* |
| DMSO | 1 | 3 h | + | 7979 | 20 | 1 | 0 | 0 | 0.26 ± 0.04 | 590 | 3110 | 59 | 228 | 1.97 ± 0.08 |
| CP | 45 | 3 h | + | 7831 | 161 | 8 | – | – | 2.11 ± 0.26 | 1968 | 1722 | 135 | 175 | 1.63 ± 0.09 |
| Sitagliptin | 250 | 3 h | + | 7976 | 24 | 0 | 0 | 0 | 0.30 ± 0.12 | 525 | 3220 | 50 | 202 | 1.98 ± 0.05 |
| Sitagliptin | 500 | 3 h | + | 7981 | 17 | 2 | 0 | 0 | 0.24 ± 0.09 | 577 | 3132 | 62 | 233 | 1.99 ± 0.05 |
| Sitagliptin | 1000 | 3 h | + | 7974 | 26 | 0 | 0 | 0 | 0.33 ± 0.06 | 598 | 3256 | 22 | 119 | 1.91 ± 0.05 |
* Significantly different from the solvent control p < 0.05 (ANOVA)